Cantor Fitzgerald Analysts Boost Earnings Estimates for …

Rigel Pharmaceuticals (RIGL) Stock Forecast & Price TargetRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives ... - MarketBeat

$15.00
OFF

Cantor Fitzgerald Issues Positive Forecast For Rigel Pharmaceuticals ...

1 week from now

Dec 11, 2024 · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price lifted by Cantor Fitzgerald from $15.00 to $25.00 in a research report released on Tuesday …

etfdailynews.com

$25
OFF

Rigel Pharmaceuticals Price Target Raised To $25 From $15 At …

1 week from now

Dec 10, 2024 · Cantor Fitzgerald raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $25 from $15 and keeps a Neutral rating on the shares. Rigel announced initial data from the …

nasdaq.com

$15.00
OFF

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives ... - MarketBeat

1 week from now

Jan 3, 2025 · Cantor Fitzgerald increased their price target on shares of Rigel Pharmaceuticals from $15.00 to $25.00 and gave the company a "neutral" rating in a research report on …

marketbeat.com

$15.00
OFF

Cantor Fitzgerald Boosts Rigel Pharmaceuticals (NASDAQ:RIGL) …

1 week from now

Dec 13, 2024 · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price hoisted by Cantor Fitzgerald from $15.00 to $25.00 in a report published on Tuesday,Benzinga …

americanbankingnews.com

$25.00
OFF

Cantor Fitzgerald Remains A Hold On Rigel (RIGL)

1 week from now

Dec 10, 2024 · In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Hold rating on Rigel (RIGL – Research Report), with a price target of $25.00. The company’s …

businessinsider.com

$25.00
OFF

Rigel Pharmaceuticals - Benzinga

1 week from now

The latest price target for Rigel Pharmaceuticals (NASDAQ:RIGL) was reported by Cantor Fitzgerald on December 10, 2024. The analyst firm set a price target for $25.00 expecting …

benzinga.com

$25
OFF

Rigel’s Robust Financial Performance And Strategic Partnerships …

1 week from now

Nov 8, 2024 · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald TipRanks 31d Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley

businessinsider.com

$15.00
OFF

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Pass Above 200

1 week from now

Dec 26, 2024 · Cantor Fitzgerald boosted their target price on Rigel Pharmaceuticals from $15.00 to $25.00 and gave the company a "neutral" rating in a research note on Tuesday, December …

marketbeat.com

$25
OFF

Rigel Pharmaceuticals Inc. Q3 Earnings Summary - Markets Insider

1 week from now

Nov 7, 2024 · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald TipRanks 31d Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley

businessinsider.com

$10
OFF

Summary - RIGL - NASDAQ - Weiss Ratings

1 week from now

Dec 11, 2024 · The Weiss investment rating of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is C-. ... Rigel Pharmaceuticals price target raised by $10 at Cantor Fitzgerald, here's why …

weissratings.com

$57
OFF

Rigel Pharmaceuticals Reports Preliminary Q4 Results; Issues 2025 ...

1 week from now

3 days ago · (RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. …

businessinsider.com

$57
OFF

Rigel Pharmaceuticals Sees Q4 Revenue $57.6M, Consensus $47.42M

1 week from now

4 days ago · While Rigel is still determining final results for the fourth quarter of 2024, the company expects to report fourth quarter total revenue of $57.6M, compared to $35.8M for the …

businessinsider.com

FAQs about Cantor Fitzgerald Analysts Boost Earnings Estimates for … Coupon?

What is the forecast for Rigel Pharmaceuticals stock?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Rigel Pharmaceuticals is $36.20, with a high forecast of $57.00 and a low forecast of $23.00. Should I buy or sell Rigel Pharmaceuticals stock right now? ...

Should you buy Rigel Pharmaceuticals stock?

The consensus among Wall Street research analysts is that investors should "hold" RIGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RIGL, but not buy additional shares or sell existing shares. Does Rigel Pharmaceuticals's stock price have much upside? ...

How will Rigel perform in the fourth quarter of 2024?

While Rigel is still determining final results for the fourth quarter of 2024, the company expects to report fourth quarter total revenue of $57.6M, compared to $35.8M for the same period of 2023. Rigel expects to report fourth quarter net product sales of $46.5M, compared to $29.5M for the same period of 2023. ...

Can Great West Life Assurance Co buy Rigel Pharmaceuticals (Rigl)?

Great West Life Assurance Co. Can Buys 70,363 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. ...

What is Rigel Pharmaceuticals' fourth quarter revenue?

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. Rigel expects to report fourth quarter net product sales of $46.5 million, compared to $29.5 million for the same period of 2023. ...

How much revenue does Rigel expect in 2023?

For the full year, Rigel expects to report total revenue of $179.3 million, including net product sales of $144.9 million, compared to total revenue of $116.9 million in 2023, which included net product sales of $104.3 million. ...